Neoadjuvant Chemotherapy: Clinical Trials

15 trials for Neoadjuvant Chemotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 recruiting, 4 unknown, 3 completed, 1 active not recruiting. 15 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 315Recruiting 5, Unknown 4, Completed 3, Active not recruiting 1, Not yet recruiting 1, Suspended 1
Phase 23Completed 1, Recruiting 1, Unknown 1

Follow Neoadjuvant Chemotherapy: new trials by email Literature Review of Neoadjuvant Chemotherapy trials Research Report on Neoadjuvant Chemotherapy

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Megestrol Acetate in Improving Neoadjuvant Chemotherapy-Related Weight Loss in Locally Advanced CRC
Megestrol Acetate - Neoadjuvant Chemotherapy, Weight Loss
Phase 3RecruitingSixth Affiliated Hospital, Sun Yat-sen University602025-11-112025-12-12
Standard or Prolonged Neoadjuvant Chemotherapy Before Surgery for BR/LAPC
FOLFIRINOX or gemcitabine-nab-paclitaxel - Locally Advanced Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Carcinoma
Phase 3RecruitingSahlgrenska University Hospital4322023-10-182024-12-03
NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)
Folfirinox - Resectable Pancreatic Cancer, Neoadjuvant Chemotherapy
Phase 3RecruitingSeoul National University Hospital6092023-04-012024-11-27
Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer
Fasting Mimicking diet program - Fasting Mimicking Diet, HER2-negative Breast Cancer
Phase 3SuspendedLeiden University Medical Center102023-03-172023-11-22
Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patients: A Randomized Phase III Trial
Albumin-Bound Paclitaxel, Carboplatin - Cervical Cancer, Neoadjuvant Chemotherapy
Phase 3RecruitingSun Yat-sen University2802022-03-142022-05-10
Dragon III-Phase 3: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer
Chemotherapy - Gastric Cancer, Neoadjuvant Chemotherapy
Phase 3Not yet recruitingRuijin Hospital2462021-09-012021-07-19
Comparison of the Pathological Effect Between 2 and 4 Cycles Neoadjuvant CAPOX for Low/Intermediate Risk II/III Rectal Cancer
Capox chemotherapy - Rectal Cancer, Neoadjuvant Chemotherapy
Phase 3Active not recruitingWest China Hospital5542021-08-262025-07-11
Paclitaxel i.v. Plus Cisplatin i.p for NACT in Patients With Advanced Ovarian Cancer
cisplatin i.p. - Epithelial Carcinoma, Ovarian, Neoadjuvant Chemotherapy
Phase 3UnknownWest China Second University Hospital502021-08-042021-08-10
Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer
gemcitabine and cisplatin - Cervical Cancer, Neoadjuvant Chemotherapy
Phase 3UnknownChuangzhen Chen2902021-07-012024-02-06
Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer
Epirubicin, Cyclophosphamid, Docetaxel - HER2-negative Breast Cancer, Neoadjuvant Chemotherapy
Phase 2 / Phase 3RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine2602020-09-202021-08-12
A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients
4 cycles of Neoadjuvant Chemotherapy With Definitive Radiotherapy, 3 cycles of Neoadjuvant Chemotherapy With concurrent chemoradiotherapy - Nasopharyngeal Carcinoma, Neoadjuvant Chemotherapy
Phase 3UnknownSecond Affiliated Hospital, Zhejiang University, School of Medicine2462019-08-012020-05-12
Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer
AG regimen, mFolfirinox - Pancreatic Adenocarcinoma Resectable, Neoadjuvant Chemotherapy
Phase 3CompletedSecond Affiliated Hospital, Zhejiang University, School of Medicine3242018-10-202025-05-13
Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy
Epirubicin, Fluorouracil, Docetaxel - Breast Cancer, Pathological Complete Response
Phase 2 / Phase 3UnknownZhiyong Yu2002017-11-272017-11-21
Melatonin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response in Locally Advanced Oral Squamous Cell Carcinoma
Melatonin 20 MG Oral Capsule, Placebo oral capsule - Oral Squamous Cell Carcinoma, Neoadjuvant Chemotherapy
Phase 3CompletedUniversitas Indonesia502017-07-042019-12-09
DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer
Fasting mimicking diet - Fasting Mimicking Diet, Breast Cancer
Phase 2 / Phase 3CompletedLeiden University Medical Center1312014-02-012019-10-24

Narrower conditions

Breast Neoplasms (2)  ·  Pancreatic Neoplasms (2)  ·  Uterine Cervical Neoplasms (2)  ·  Adenocarcinoma (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Nasopharyngeal Carcinoma (1)  ·  Rectal Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Stomach Neoplasms (1)  ·  Weight Loss (1)

Broader conditions

Neoplasms (11)  ·  Neoplasms by Site (11)  ·  Carcinoma (4)  ·  Digestive System Diseases (4)  ·  Digestive System Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Endocrine Gland Neoplasms (3)  ·  Endocrine System Diseases (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genital Diseases (3)  ·  Genital Diseases, Female (3)  ·  Genital Neoplasms, Female (3)  ·  Urogenital Diseases (3)

Interventions

Cyclophosphamide (2)  ·  Docetaxel (2)  ·  Epirubicin (2)  ·  Fluorouracil (2)  ·  Gemcitabine (2)  ·  folfirinox (2)  ·  130-nm albumin-bound paclitaxel (1)  ·  Albumin-Bound Paclitaxel (1)  ·  Carboplatin (1)  ·  Chemoradiotherapy (1)  ·  Cisplatin (1)  ·  Doxorubicin (1)  ·  Drug Therapy (1)  ·  Folic Acid (1)  ·  Irinotecan (1)

Sponsors

Second Affiliated Hospital, Zhejiang University, School of Medicine (3)  ·  Leiden University Medical Center (2)  ·  Chuangzhen Chen (1)  ·  Ruijin Hospital (1)  ·  Sahlgrenska University Hospital (1)  ·  Seoul National University Hospital (1)  ·  Sixth Affiliated Hospital, Sun Yat-sen University (1)  ·  Sun Yat-sen University (1)  ·  Universitas Indonesia (1)  ·  West China Hospital (1)  ·  West China Second University Hospital (1)  ·  Zhiyong Yu (1)

Countries

China (9)  ·  Netherlands (2)  ·  Indonesia (1)  ·  South Korea (1)  ·  Sweden (1)

Top investigators

Birendra K Sah, PH D (1)  ·  Chen Li, PH D (1)  ·  Chuangzhen Chen, MD (1)  ·  Diani Kartini, MD (1)  ·  Elena Rangelova, PhD (1)  ·  Hanno Pijl, MD PhD (1)  ·  Judith R Kroep, MD, PhD (1)  ·  Judith R Kroep, PhD (1)  ·  Jun Huang, PhD. (1)  ·  Qichun Wei (1)  ·  Tingbo Liang, MD PhD (1)  ·  Wooil Kwon (1)  ·  Xiaoshan Cao, MD (1)  ·  Yiding Chen (1)

Results publications

PMID 32372215, PMID 32576828, PMID 33179154, PMID 37312165